Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2007 by Asociación para Evitar la Ceguera en México.
Recruitment status was:  Recruiting
Information provided by:
Asociación para Evitar la Ceguera en México Identifier:
First received: June 30, 2006
Last updated: November 29, 2007
Last verified: November 2007
To investigate the feasibility and advantages of using pressurized perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting 23 GA vitrectomy using a dual, dynamic drive (3D)technology, in complicated retinal detachment surgeries.

Condition Intervention Phase
Retinal Detachment
Procedure: Vitrectomy
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Pressurized Perfluorocarbon Perfused 23 GA Vitrectomy in Complicated Diabetic Retinal Detachment

Resource links provided by NLM:

Further study details as provided by Asociación para Evitar la Ceguera en México:

Primary Outcome Measures:
  • Perfluorocarbon liquids consumption [ Time Frame: two months ]

Estimated Enrollment: 10
Study Start Date: March 2007
Estimated Study Completion Date: February 2008
Intervention Details:
    Procedure: Vitrectomy
    pressurized 23GA vitrectomy with a 3D system

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Complicated retinal detachment with no more than 6months of evolution

Exclusion Criteria:

  • Retinal detachments of more than 6 months of evolution No light perception
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00404209

Contact: Hugo Quiroz-Mercado, MD 5255 10841400 ext 1171

Asociación para Evitar la Ceguera en México, Hospital "Luis Sánchez Bulnes" Recruiting
Mexico City, Mexico DF, Mexico, 04030
Contact: Hugo Quiroz-Mercado, MD    5255 10841400 ext 1171   
Sub-Investigator: Maria A Martinez-Castellanos, MD         
Sub-Investigator: Gerardo Garcia-Aguirre, MD         
Sub-Investigator: Orlando Ustariz-Gonzalez, MD         
Sub-Investigator: Jose L Guerrero-Naranjo, MD         
Sub-Investigator: Jans Fromow-Guerra, MD         
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Principal Investigator: Hugo Quiroz-Mercado, MD Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes"
Principal Investigator: Raul Velez-Montoya, MD Asociación para Evitar la Ceguera en México
  More Information

Responsible Party: Hugo Quiroz-Mercado, Asociacion para evitar la ceguera en Mexico Identifier: NCT00404209     History of Changes
Other Study ID Numbers: APEC-008
Study First Received: June 30, 2006
Last Updated: November 29, 2007

Additional relevant MeSH terms:
Dissociative Disorders
Retinal Detachment
Mental Disorders
Retinal Diseases
Eye Diseases processed this record on May 25, 2017